Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-18-057995

Director acquired 8,577,248 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BioLexis Pte Ltd. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-11-07 Grant or award : show line 1 in the form +8,577,248 $0.93 $7,999,999 52,904,631 D
Loading xslF345X03/doc4.xml…